申请人:Sandoz, Inc.
公开号:US04582848A1
公开(公告)日:1986-04-15
This disclosure relates to substituted indolamines, which exhibit anti-diabetic activity, having the formula: ##STR1## where m is an integer from 1 to 4, x represents hydrogen or --OH R represents Ar or ##STR2## and Ar represents ##STR3## R.sub.1 represents hydrogen, fluoro, chloro, lower alkyl or lower alkoxy, R.sub.2 and R.sub.3 each, independently, represent lower alkyl, or R.sub.2 and R.sub.3 together with N represent ##STR4## wherein n is 1, 2 or 3, R.sub.4 represents hydrogen or lower alkyl, and R.sub.5 represents hydrogen or lower alkyl, unsubstituted phenyl or phenyl substituted with fluoro, chloro, lower alkyl or lower alkoxy, or or pharmaceutically acceptable acid addition salts thereof.
这项披露涉及取代吲哚胺,其具有抗糖尿病活性,其化学式为:##STR1##其中m是1到4之间的整数,x代表氢或--OH,R代表Ar或##STR2##,Ar代表##STR3##,R.sub.1代表氢、氟、氯、较低烷基或较低烷氧基,R.sub.2和R.sub.3各自独立地代表较低烷基,或R.sub.2和R.sub.3与N一起代表##STR4##其中n为1、2或3,R.sub.4代表氢或较低烷基,R.sub.5代表氢或较低烷基,未取代的苯基或苯基取代的氟、氯、较低烷基或较低烷氧基,或其药用可接受的酸盐。